Texas Attorney General Ken Paxton has launched a lawsuit against pharmaceutical giants Sanofi and Bristol-Myers Squibb, ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

Starting in October, drug companies will start rolling out generic versions of several widely used but expensive drugs. The top two sellers are the cholesterol drug Lipitor and the blood-thinner ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.

Bristol-Myers Squibb said generic competition on its biggest drug, Plavix, hamstrung third-quarter earnings, while a federal probe expanded to determine whether an ill-fated deal to protect the Plavix ...

An appeals court denies a motion to stay a ruling that stopped generic sales of the Bristol-Myers drug. A federal appeals court on Thursday ruled that Canadian company can't resume shipping generic ...

Generic competition will decimate sales of the brand-name drugs and slash the cost to patients and companies that provide health benefits. Top drugs getting generic competition by September 2012 are ...

AP - The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration said Friday that it will require a new ...

In addition, there were no significant differences between the drug groups in the percent of patients who died or were hospitalized for any reason; had a stroke or transient ischemic attack ; or who ...

NEW YORK — An economics professor at the Massachusetts Institute of Technology testified Monday that there will be “significant price erosion” in the drug Plavix, even if a federal judge grants a ...